Drug Trial Radar · NCT05052801
Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression
Last checked: Nov 19, 2026Latest source record: Oct 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
547
Actual
Start
Mar 7, 2022
Primary completion
Jun 20, 2025
Study completion Apr 26, 2026
Sponsor
- Lead sponsor
- AmgenAmgen (AMGN)
- Sponsor type
- Industry
- Collaborators
- Zai Lab (China only)
- First posted
- Sep 22, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 100 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main objective of this study is to compare efficacy of bemarituzumab combined with oxaliplatin, leucovorin, and 5-fluorouracil (5-FU) (mFOLFOX6) to placebo plus mFOLFOX6 as assessed by overall survival (OS) in participants with FGFR2b ≥10% 2+/3+ tumor cell staining (FGFR2b ≥10% 2+/3+TC)
Conditions
- Gastric Cancer
- Gastroesophageal Junction Adenocarcinoma
Interventions
BemarituzumabDrug
Intravenous (IV) infusion
mFOLFOX6Drug
mFOLFOX6 administered as a combination of oxaliplatin and leucovorin as IV infusions. 5-FU administered as bolus followed by additional administration as IV infusion.
PlaceboDrug
IV infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall SurvivalTime frame: Up to approximately 3.5 years
Locations
300 sites in 37 countries. Site status is shown where the registry gives one.
Alaska Oncology and Hematology
Anchorage, Alaska
Mayo Clinic Arizona
Phoenix, Arizona
The Oncology Institute Clinical Research
Cerritos, California
University of California Los Angeles
Los Angeles, California
Mayo Clinic Florida
Jacksonville, Florida
Saint Francis Medical Group
Indianapolis, Indiana
University of Michigan
Ann Arbor, Michigan
Mayo Clinic Rochester
Rochester, Minnesota
Healthier Hematology and Oncology Excelsior Integrated Medical Group
Brooklyn, New York
White Plains Hospital Center for Cancer Care
White Plains, New York
Levine Cancer Institute University
Charlotte, North Carolina
FirstHealth Cancer Center
Pinehurst, North Carolina
Avera Cancer Institute
Sioux Falls, South Dakota
Vanderbilt University Medical Center
Nashville, Tennessee
Inova Schar Cancer Institute
Fairfax, Virginia
Medical Oncology Associates, PS
Spokane, Washington
Instituto Argentino de Diagnostico y Tratamiento IADT
Buenos Aires, Argentina
Hospital Britanico de Buenos Aires
Buenos Aires, Argentina
Instituto Alexander Fleming
CABA, Buenos Aires, Argentina
Hospital Universitario Fundacion Favaloro
Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
Sociedad de Beneficencia Hospital Italiano
Córdoba, Córdoba Province, Argentina
Hospital Privado Universitario de Cordoba
Córdoba, Córdoba Province, Argentina
Hospital Provincial del Centenario
Rosario, Santa Fe Province, Argentina
Exelsus Oncologia Clinica
San Miguel de Tucumán, Tucumán Province, Argentina
Liverpool Hospital
Liverpool, New South Wales, Australia
St John of God Murdoch Hospital
Murdoch, Western Australia, Australia
Universitair Ziekenhuis Antwerpen
Edegem, Belgium
Universitair Ziekenhuis Gent
Ghent, Belgium
Universitair Ziekenhuis Leuven - Campus Gasthuisberg
Leuven, Belgium
Centre Hospitalier Universitaire de Liege - Sart Tilman
Liège, Belgium
Instituto Nacional de Cancer
Rio de Janeiro, Brazil
Hospital Nove de Julho - dasa
São Paulo, Brazil
Instituto Brasileiro de Controle do Cancer Ibcc
São Paulo, Brazil
Núcleo de Oncologia da Bahia
Salvador, Estado de Bahia, Brazil
Centro de Oncologia Mackenzie
Curitiba, Paraná, Brazil
Oncosite Centro de Pesquisa Clinica Em Oncologia Ltda
Ijuí, Rio Grande do Sul, Brazil
Hospital Sao Lucas da Pontificia Universidade Catolica do Rio Grande do Sul
Porto Alegre, Rio Grande do Sul, Brazil
Clinica de Oncologia Reichow
Blumenau, Santa Catarina, Brazil
Centro de Pesquisa e Ensino em Oncologia de Santa Catarina
Florianópolis, Santa Catarina, Brazil
Instituto de Ensino e Pesquisa Sao Lucas Iep Sao Lucas
Santo André, São Paulo, Brazil
Showing 40 of 300 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.